Processive MedTech Development Services ApS: Financial statements 2022
CVR: 41589604
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Processive MedTech Development Services ApS (CVR 41589604) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,807,753 and a net result of DKK 356,577 compared with DKK 107,443 the year before. That is an increase of 21.4% compared with the year before. Equity in the 2022 report amounted to DKK 369,601. The solvency ratio was 54.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,807,753
- Profit/Loss
- DKK 356,577
- Equity
- DKK 369,601
- Total Assets
- DKK 683,468
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.8 mio. | 357 t. | 370 t. | 2 |
| 2021 | - | 1.5 mio. | 107 t. | 147 t. | 2 |
Official annual report
Keep an eye on Processive MedTech Development Services ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Processive MedTech Development Services ApS
Processive MedTech Development Services ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The management consists of Maria Lund Jensen and Miles Barnaby Gerrard. The company is owned by Isar Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,020,213 and a net result of DKK 333,431 compared with DKK -206,835 the year before. Equity in the 2025 report amounted to DKK 534,798.